Finance

Lists
AHCO:NASDAQ
Adapthealth Corp
6,25 US$
-1,26%
(-0,080) 1D
6,25 US$
0,00% (0,00)
After hours
Closed: 14 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AHCO...
Open
6,32 US$
High
6,38 US$
Low
6,20 US$
Mkt. cap
852,15 მლნ.
Avg. vol.
2,62 მლნ.
Volume
1,82 მლნ.
52-wk high
13,43 US$
52-wk low
5,21 US$
EPS
-1,68 US$
Beta
1,42
Shares outstanding
136,34 მლნ.
No. of employees
11 ათ.
Open
6,32 US$
High
6,38 US$
Low
6,20 US$
Mkt. cap
852,15 მლნ.
Avg. vol.
2,62 მლნ.
Volume
1,82 მლნ.
52-wk high
13,43 US$
52-wk low
5,21 US$
EPS
-1,68 US$
Beta
1,42
Shares outstanding
136,34 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
About Adapthealth Corp
CEO-
Employees10,9 ათ.
Founded2012
HeadquartersConshohocken, პენსილვანია, ამერიკის შეერთებული შტატები
SectorHealth care provider
Analyst ratings
Based on 6 analysts giving stock ratings to AHCO in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AHCO in the last 3 months.
Highest
Current 6,25 US$
10,00 US$ (+60,00%)
Average
9,40 US$ (+50,40%)
Lowest
8,00 US$ (+28,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Coldwell
Robert W. Baird
Buy
Maintained
9,00 US$
+44%
09/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
10,00 US$
+60%
09/15/2026
David S Macdonald
Truist Financial
Buy
Maintained
-
-
09/09/2026
Richard Close
Canaccord Genuity
Buy
Maintained
10,00 US$
+60%
09/09/2026
Kevin Caliendo
UBS
Buy
Reiterated
10,00 US$
+60%
08/24/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
8,00 US$
+28%
08/05/2026
Jack Slevin
Jefferies
Buy
Upgraded
13,00 US$
+108%
07/21/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
9,50 US$
+52%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
820,31 მლნ.
846,29 მლნ.
679,87 მლნ.
740,31 მლნ.
Cost of goods sold
639,98 მლნ.
661,38 მლნ.
563,34 მლნ.
611,86 მლნ.
Cost of revenue
639,98 მლნ.
661,38 მლნ.
563,34 მლნ.
611,86 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
103,10 მლნ.
122,54 მლნ.
114,78 მლნ.
114,26 მლნ.
Operating expense
113,20 მლნ.
132,47 მლნ.
121,95 მლნ.
122,21 მლნ.
Total operating expenses
753,18 მლნ.
793,85 მლნ.
685,29 მლნ.
734,07 მლნ.
Operating income
67,13 მლნ.
52,44 მლნ.
-5,42 მლნ.
6,24 მლნ.
Other non operating income
-
726,00 ათ.
-
-
EBT including unusual items
36,35 მლნ.
-97,99 მლნ.
-31,02 მლნ.
-165,33 მლნ.
EBT excluding unusual items
41,75 მლნ.
28,72 მლნ.
-31,02 მლნ.
-19,97 მლნ.
Income tax expense
10,60 მლნ.
3,54 მლნ.
-7,16 მლნ.
-21,23 მლნ.
Effective tax rate
29,16%
-3,62%
23,10%
12,84%
Other operating expenses
-
-
-
-
Net income
24,51 მლნ.
-102,77 მლნ.
-16,04 მლნ.
-133,93 მლნ.
Net profit margin
2,99%
-12,14%
-2,36%
-18,09%
Earnings per share
0,23
0,27
-0,05
-0,07
Interest and investment income
-
-
-
-
Interest expense
-25,38 მლნ.
-24,44 მლნ.
-25,59 მლნ.
-26,21 მლნ.
Net interest expenses
-25,38 მლნ.
-24,44 მლნ.
-25,59 მლნ.
-26,21 მლნ.
Depreciation and amortization charges
10,10 მლნ.
9,93 მლნ.
7,17 მლნ.
7,95 მლნ.
EBITDA
157,75 მლნ.
149,94 მლნ.
106,09 მლნ.
131,57 მლნ.
Gain or loss from assets sale
-
-377,00 ათ.
-
-6,27 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები